Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals

The cancer center will now bar top officials from sitting on outside boards of for-profit companies, and is conducting a wide-scale review of other policies.
By KATIE THOMAS and CHARLES ORNSTEIN from NYT Health https://nyti.ms/2RpLXYc
via IFTTT
Boards of Directors, Drugs (Pharmaceuticals)
Source The New York Times
Làm đẹp Blog 247